09.17.20

Oxford Says AstraZeneca Trial Illnesses May Not Be Linked to COVID-19 Vaccine

Source: FirstWord

09.16.20

FDA Probes Whether to Allow AstraZeneca to Resume COVID-19 Vaccine Trial in US

Source: FirstWord

09.14.20

AstraZeneca Resumes COVID-19 Vaccine Trials

Source: FirstWord

09.09.20

AstraZeneca Pauses COVID-19 Vaccine Trial Amid Safety Concern

Source: FirstWord

09.01.20

AstraZeneca Kicks Off Phase 3 Study of COVID-19 Vaccine AZD1222 in the US

Source: FirstWord

07.16.20

Reports Hint at Positive Data Coming for AstraZeneca, Oxford Coronavirus Vaccine

Source: FirstWord

06.15.20

AstraZeneca to Supply Europe Up to 400 Million COVID-19 Vaccine Doses

Source: FirstWord

View more stories